Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Jul 2, 2018 at 12:05 PM EDT

Why Nuvectra Is Monday’s Big Biotech Loser

Nuvectra shares were crushed on Monday after the company announced an update on its FDA premarket approval application and its…

Douglas A. McIntyre | Jul 2, 2018 at 11:35 AM EDT

July Fourth Heat and Your Health

The fireworks may not be all that we see in the sky this Fourth of July as much of the…

Chris Lange | Jul 2, 2018 at 11:10 AM EDT

FDA Accepts Merck’s Keytruda for Review, Sets PDUFA Date

Merck shares retreated to start off the week despite the announcement of good news from the FDA.

Chris Lange | Jul 2, 2018 at 9:10 AM EDT

Adamis and Novartis Team Up Against Mylan

Adamis Pharmaceuticals saw its shares shoot up early on Monday after the firm announced a partnership with a subsidiary of…

Chris Lange | Jul 1, 2018 at 8:20 AM EDT

Biopharma Companies to Watch This Week

Here are a few biotech and pharmaceutical companies to watch for in the coming week and for the month of…

Chris Lange | Jun 30, 2018 at 8:15 AM EDT

Massive Biopharma Movers of the Past Week

A few biopharma stocks made massive runs over the course of this past week, some losing more than half their…

Chris Lange | Jun 29, 2018 at 11:05 AM EDT

Acceleron Pharma and Celgene Knock It Out of the Park in Late-Stage Trial

Acceleron Pharma and Celgene each saw gains on Friday after they reported results from a late-stage trial.

Chris Lange | Jun 29, 2018 at 10:25 AM EDT

Dermira Wins Big on FDA Approval

Dermira shares made a solid gain to close out the week after the firm announced a key approval from the…

Chris Lange | Jun 29, 2018 at 9:50 AM EDT

Why Gemphire Therapeutics Shares More Than Doubled

Gemphire Therapeutics shares more than doubled early on Thursday after the company announced results from a midstage trial for severe…

Paul Ausick | Jun 28, 2018 at 11:10 AM EDT

Amazon’s PillPack Purchase Wipes Out $20 Billion in Pharmacy-Related Market Cap

Amazon's announced acquisition of pharmacy firm PillPack has sent a shockwave through retail pharmacy stocks, pharmacy benefits management companies, and…

Chris Lange | Jun 28, 2018 at 10:55 AM EDT

Why Arsanis Shares Are Bombing

Arsanis shares were absolutely crushed on Thursday after the company provided an update from its midstage trial. The company decided…

Chris Lange | Jun 28, 2018 at 10:30 AM EDT

Akebia and Keryx Combine to Fight Chronic Kidney Disease

Akebia Therapeutics and Keryx Biopharmaceuticals each saw their shares take a dive on Thursday following news that these two companies…

Paul Ausick | Jun 28, 2018 at 8:20 AM EDT

Why Walgreens Earnings Beat May Not Have Been Enough

The Dow's newest component, Walgreens Boots Alliance, reported quarterly earnings Thursday morning that beat estimates, but there were some weaknesses,…

Chris Lange | Jun 27, 2018 at 1:05 PM EDT

Short Sellers Hike Bets in Major Pharma Stocks

The June 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jun 27, 2018 at 12:10 PM EDT

Pain Therapeutics Shares Reeling After FDA Vote

Pain Therapeutics shares were destroyed on Wednesday after a vote from the FDA was announced.

1 … 127 128 129 130 131 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why Nuvectra Is Monday’s Big Biotech Loser

July Fourth Heat and Your Health

FDA Accepts Merck’s Keytruda for Review, Sets PDUFA Date

Adamis and Novartis Team Up Against Mylan

Biopharma Companies to Watch This Week

Massive Biopharma Movers of the Past Week

Acceleron Pharma and Celgene Knock It Out of the Park in Late-Stage Trial

Dermira Wins Big on FDA Approval

Why Gemphire Therapeutics Shares More Than Doubled

Amazon’s PillPack Purchase Wipes Out $20 Billion in Pharmacy-Related Market Cap

Why Arsanis Shares Are Bombing

Akebia and Keryx Combine to Fight Chronic Kidney Disease

Why Walgreens Earnings Beat May Not Have Been Enough

Short Sellers Hike Bets in Major Pharma Stocks

Pain Therapeutics Shares Reeling After FDA Vote

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Health and Healthcare Articles

All Health and Healthcare Articles

Why Nuvectra Is Monday’s Big Biotech Loser

July Fourth Heat and Your Health

FDA Accepts Merck’s Keytruda for Review, Sets PDUFA Date

Adamis and Novartis Team Up Against Mylan

Biopharma Companies to Watch This Week

Massive Biopharma Movers of the Past Week

Acceleron Pharma and Celgene Knock It Out of the Park in Late-Stage Trial

Dermira Wins Big on FDA Approval

Why Gemphire Therapeutics Shares More Than Doubled

Amazon’s PillPack Purchase Wipes Out $20 Billion in Pharmacy-Related Market Cap

Why Arsanis Shares Are Bombing

Akebia and Keryx Combine to Fight Chronic Kidney Disease

Why Walgreens Earnings Beat May Not Have Been Enough

Short Sellers Hike Bets in Major Pharma Stocks

Pain Therapeutics Shares Reeling After FDA Vote

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how